Pot Stocks On The Rise With Potential Cannabis Rescheduling In 2025

Industry Overview - The cannabis industry in the USA is currently experiencing a significant push for federal reform, which has been a long-standing goal since states began legalizing cannabis. This reform is crucial but has also created challenges for investors and legal operators due to the grey area of legality [1][2] - Despite the ongoing challenges, the demand for cannabis continues to rise, supported by positive earnings reports from the second quarter of 2025 and renewed investor interest following comments from former President Trump regarding federal reform [2][3] Company Highlights - Green Thumb Industries Inc.: This company manufactures, distributes, markets, and sells cannabis products for both medical and adult use in the United States. Recently, it announced a transaction to sell certain consumer packaged goods brands to Agrify Corporation, along with a $45 million loan to Agrify [4][8] - Curaleaf Holdings, Inc.: Curaleaf has been selected for inclusion in the S&P/TSX Composite Index, effective September 22, 2025. This inclusion signifies a major milestone for the company, enhancing its visibility and positioning within the market [11][12] - Cresco Labs Inc.: The company recently closed a $325 million senior secured term loan refinancing with a 12.5% interest rate, maturing on August 13, 2030. This refinancing replaces a previous $360 million facility, aiming to reduce total debt and provide more flexibility for prepayment [12][14]